首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >NOEY2 (ARHI) an imprinted putative tumor suppressor gene in ovarian and breast carcinomas
【2h】

NOEY2 (ARHI) an imprinted putative tumor suppressor gene in ovarian and breast carcinomas

机译:NOEY2(ARHI)是卵巢癌和乳腺癌中的一种公认的抑癌基因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Using differential display PCR, we have identified a gene [NOEY2, ARHI (designation by the Human Gene Nomenclature Committee)] with high homology to ras and rap that is expressed consistently in normal ovarian and breast epithelial cells but not in ovarian and breast cancers. Reexpression of NOEY2 through transfection suppresses clonogenic growth of breast and ovarian cancer cells. Growth suppression was associated with down-regulation of the cyclin D1 promoter activity and induction of p21WAF1/CIP1. In an effort to identify mechanisms leading to NOEY2 silencing in cancer, we found that the gene is expressed monoallelically and is imprinted maternally. Loss of heterozygosity of the gene was detected in 41% of ovarian and breast cancers. In most of cancer samples with loss of heterozygosity, the nonimprinted functional allele was deleted. Thus, NOEY2 appears to be a putative imprinted tumor suppressor gene whose function is abrogated in ovarian and breast cancers.
机译:使用差异显示PCR,我们已经鉴定了与ras和rap具有高度同源性的基因[NOEY2,ARHI(人类基因命名委员会指定)],该基因在正常卵巢和乳腺癌上皮细胞中始终表达,但在卵巢癌和乳腺癌中不表达。通过转染重新表达NOEY2可抑制乳腺癌和卵巢癌细胞的克隆生长。生长抑制与细胞周期蛋白D1启动子活性的下调和p21 WAF1 / CIP1 的诱导有关。为了确定导致癌症中NOEY2沉默的机制,我们发现该基因单等位表达且在母体中有印记。在41%的卵巢癌和乳腺癌中检测到该基因的杂合性丧失。在大多数杂合性丧失的癌症样本中,未标记的功能等位基因被删除。因此,NOEY2似乎是一个假定的印迹抑癌基因,其功能在卵巢癌和乳腺癌中被废止。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号